Welcome to our dedicated page for Tenet Healthcare news (Ticker: THC), a resource for investors and traders seeking the latest updates and insights on Tenet Healthcare stock.
Tenet Healthcare Corporation reports developments across a diversified healthcare services business that combines ambulatory surgery, hospital operations and healthcare-services outsourcing. Its care delivery network includes United Surgical Partners International, which operates ambulatory surgery centers and surgical hospitals, along with acute care and specialty hospitals, outpatient facilities, employed physician networks and a global business center in Manila.
Recurring news themes for THC include quarterly earnings, financial outlooks, same-facility revenue trends, Ambulatory and Hospital segment performance, payer-mix and expense-management commentary, and capital or ownership actions involving Conifer Health Solutions. Company updates also cover Conifer's revenue cycle management and value-based care services for hospitals, health systems, physician practices, employers and other clients, as well as Tenet's presentations at healthcare investor conferences.
Tenet Healthcare Corporation (NYSE: THC) will announce its first quarter 2023 results on April 25, 2023, before the market opens. Following this, a conference call will take place at 9:00 a.m. CT (10:00 a.m. ET). Investors can access a live webcast and an audio archive of the call via the investor relations section of Tenet's website.
Tenet is a diversified healthcare services company based in Dallas, operating 61 hospitals and more than 465 ambulatory surgery centers. Its subsidiary, Conifer Health Solutions, provides essential services to various healthcare clients.
Tenet Healthcare Corporation (NYSE: THC) will present at the Barclays Global Healthcare Conference on March 14, 2023, at 9:30 a.m. Eastern time. Investors can access a live webcast and audio archive via the investor relations section of Tenet's website. The replay will be available for 30 days.
Headquartered in Dallas, Tenet is a diversified healthcare services company with a wide range of facilities, including over 465 ambulatory surgery centers. The company operates 61 acute care and specialty hospitals and offers revenue cycle management through its subsidiary, Conifer Health Solutions.
Tenet Healthcare Corporation (NYSE: THC) reported a fourth quarter 2022 net income of $102 million, or $0.92 per diluted share, down from $250 million in the same quarter of 2021. Adjusted EBITDA for the quarter was $897 million, including $40 million of grant income. Ambulatory Care adjusted EBITDA grew 18.7% year-over-year. The company repurchased 5.9 million shares for $250 million. For FY 2023, Tenet expects adjusted EBITDA between $3.160 billion and $3.360 billion. Challenges included lower COVID-related volumes and elevated labor costs contributing to reduced profitability.
United Surgical Partners International (USPI), a subsidiary of Tenet Healthcare (NYSE: THC), has expanded its partnership with Providence, a not-for-profit health system. This new development agreement aims to enhance the quality and access to ambulatory surgical services in various communities, particularly in California and Washington. The partnership builds upon a long-standing relationship initiated in 2004, which has already resulted in five ambulatory surgery centers. The collaboration will focus on improving patient care and exploring further opportunities for joint ventures in the Western U.S. throughout 2023 and 2024.
Summary not available.
Tenet Healthcare Corporation (NYSE: THC) anticipates exceeding the midpoint of its FY22 Adjusted EBITDA Outlook, projected at $3.425 billion, despite not finalizing all financials. CEO Saum Sutaria highlighted strong management capabilities across all business units. Leadership updates include the retirement of key executives, with ongoing searches for successors. Daniel Cancelmi and Brett Brodnax will retire at the end of 2023, while Roger Davis will step down in Q1 2023. New promotions within operational leadership aim to enhance strategic execution and operational consistency, reinforcing Tenet's commitment to performance.
Tenet Healthcare Corporation (NYSE: THC) is set to release its fourth quarter 2022 results on February 9, 2023, by 6:00 a.m. Central Time. This will be followed by a conference call at 9:00 a.m. CT. Investors can access a live webcast and audio archive of the call through the investor relations section of Tenet's website.
Headquartered in Dallas, Tenet's extensive healthcare network includes over 465 ambulatory surgery centers, 61 acute care hospitals, and Conifer Health Solutions for revenue cycle management. The company is committed to providing quality healthcare in the communities it serves.
Tenet Healthcare Corporation (NYSE: THC) will present at the BofA Securities 2022 Leveraged Finance Conference on November 29, 2022, at 8:10 a.m. Eastern time. Investors can access the live webcast and audio archive through Tenet's investor relations website, with a replay available for 30 days post-event.
Headquartered in Dallas, Tenet operates a diverse healthcare network, including over 465 ambulatory surgery centers, 61 hospitals, and various outpatient facilities, aiming to deliver quality care in the communities served.
Tenet Healthcare Corporation (NYSE: THC) will present at the Credit Suisse 31st Annual Healthcare Conference on November 8, 2022, at 11:00 a.m. Eastern time. Investors can access a live webcast and audio archive through the investor relations section of Tenet's website, where the replay will be available for 30 days. Based in Dallas, Tenet operates a diverse healthcare network, including over 465 ambulatory surgery centers and 61 acute care hospitals. Through its Conifer Health Solutions subsidiary, the company provides revenue cycle management and value-based care services.
Tenet Healthcare reported a net income of $131 million in Q3 2022, translating to $1.16 per diluted share, down significantly from $448 million in Q3 2021. Adjusted diluted EPS decreased to $1.44. Consolidated Adjusted EBITDA was $841 million, a slight decline from $855 million year-over-year. The company announced a $1 billion share repurchase program to enhance shareholder value and revised its FY 2022 Adjusted EBITDA outlook to a range of $3.375 billion to $3.475 billion.
While USPI saw a 16.4% EBITDA growth, hospital admissions dropped by 5.3% reflecting pandemic pressures.